Related Experiment Video
Updated: May 10, 2026

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Assessment and clinical course of hypocalcemia in critical illness
Insights
Hypocalcemia in critically ill patients often resolves within four days. Calcium supplementation did not improve normalization or survival rates, and adjusted calcium is an unreliable indicator of ionized calcium levels.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Nephrology
Background:
- Hypocalcemia is a frequent complication in critically ill patients.
- The clinical course and management of hypocalcemia in intensive care units (ICUs) remain unclear.
- Inconsistent assessment of calcium status complicates patient management.
Purpose of the Study:
- To determine the course of hypocalcemia during early ICU admission and its association with mortality.
- To evaluate the impact of calcium supplementation on calcium normalization and patient survival.
- To assess the reliability of adjusted calcium (AdjCa) in predicting ionized calcium (iCa) levels.
Main Methods:
- A retrospective analysis of 1,038 ICU admissions.
- Monitoring of ionized calcium (iCa) levels over the first four days of admission.
- Comparison of outcomes between normocalcemic and hypocalcemic patients, with and without calcium supplementation.
- Analysis of adjusted calcium (AdjCa) predictive accuracy using ROC curves.
Main Results:
- 55.2% of patients presented with hypocalcemia, 6.2% severely.
- Hypocalcemia typically normalized within four days; failure to normalize in severe cases correlated with higher mortality.
- Calcium supplementation did not significantly improve iCa normalization or survival rates.
- Adjusted calcium (AdjCa) demonstrated low specificity in predicting low iCa.
Conclusions:
- Hypocalcemia in ICU patients generally normalizes within four days.
- Failure to normalize iCa in severe hypocalcemia may indicate increased mortality risk.
- Calcium supplementation showed no benefit for normalization or survival; AdjCa is unreliable for assessing iCa in ICUs.
Introduction:
Hypocalcemia is common in critically ill patients. However, its clinical course during the early days of admission and the role of calcium supplementation remain uncertain, and the assessment of calcium status is inconsistent. We aimed to establish the course of hypocalcemia during the early days of critical illness in relation to mortality and to assess the impact of calcium supplementation on calcium normalization and mortality.
Methods:
Data were collected on 1,038 admissions to the critical care units of a tertiary care hospital. One gram of calcium gluconate was administered intravenously once daily to patients with adjusted calcium (AdjCa)<2.2 mmol/L. Demographic and outcome data were compared in normocalcemic (ionized calcium, iCa, 1.1-1.3 mmol/L) and mildly and severely hypocalcemic patients (iCa 0.9-1.1 mmol/L and <0.9 mmol/L, respectively). The change in iCa concentrations was monitored during the first four days of admission and comparisons between groups were made using Repeated Measures ANOVA. Comparisons of normalization and outcome were made between hypocalcemic patients who did and did not receive calcium replacement according to the local protocol. The suitability of AdjCa to predict low iCa was determined by analyzing sensitivity, specificity and receiver operating characteristic (ROC) curves. Multivariate logistic regression was performed to determine associations of other electrolyte derangements with hypocalcemia.
Results:
55.2% of patients were hypocalcemic on admission; 6.2% severely so. Severely hypocalcemic patients required critical care for longer (P=0.001) compared to normocalcemic or mildly hypocalcemic patients, but there was no difference in mortality between groups (P=0.48). iCa levels normalized within four days in most, with no difference in normalization between those who died and survived (P=0.35). Severely hypocalcemic patients who failed to normalize their iCa by day 4 had double the mortality (38% vs. 19%, P=0.15). Neither iCa normalization nor survival were superior in hypocalcemic patients receiving supplementation on admission. AdjCa<2.2 mmol/L had a sensitivity of 78.2% and specificity of 63.3% for predicting iCa<1.1 mmol/L. Low magnesium, sodium and albumin were independently associated with hypocalcemia on admission.
Conclusions:
Hypocalcemia usually normalizes within the first four days after admission to ICU and failure to normalize in severely hypocalcemic patients may be associated with increased mortality. Calcium replacement appears not to improve normalization or mortality. AdjCa is not a good surrogate of iCa in an ICU setting.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Skeleton and Calcium Homeostasis
Acute Kidney Injury III: Clinical Manifestations
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care